These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 10505797)

  • 1. Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases.
    Blandizzi C; Malizia T; Lupetti A; Pesce D; Gabriele M; Giuca MR; Campa M; Del Tacca M; Senesi S
    J Periodontol; 1999 Sep; 70(9):960-6. PubMed ID: 10505797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periodontal tissue disposition of azithromycin.
    Malizia T; Tejada MR; Ghelardi E; Senesi S; Gabriele M; Giuca MR; Blandizzi C; Danesi R; Campa M; Del Tacca M
    J Periodontol; 1997 Dec; 68(12):1206-9. PubMed ID: 9444596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between piroxicam and azithromycin during distribution to human periodontal tissues.
    Malizia T; Batoni G; Ghelardi E; Baschiera F; Graziani F; Blandizzi C; Gabriele M; Campa M; Del Tacca M; Senesi S
    J Periodontol; 2001 Sep; 72(9):1151-6. PubMed ID: 11577945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug concentration in inflamed periodontal tissues after systemically administered azithromycin.
    Gomi K; Yashima A; Iino F; Kanazashi M; Nagano T; Shibukawa N; Ohshima T; Maeda N; Arai T
    J Periodontol; 2007 May; 78(5):918-23. PubMed ID: 17470027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-stage full-mouth versus partial-mouth scaling and root planing during the effective half-life of systemically administered azithromycin.
    Yashima A; Gomi K; Maeda N; Arai T
    J Periodontol; 2009 Sep; 80(9):1406-13. PubMed ID: 19722790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dose on macrolide distribution in saliva and periodontal tissues of young patients.
    Bertazzoni Minelli E; Consolo U; Politi M; Perboni G; Miglioli PA; Gotte P
    J Chemother; 1989 Jul; 1(4 Suppl):579-80. PubMed ID: 16312541
    [No Abstract]   [Full Text] [Related]  

  • 7. Azithromycin in periodontal treatment: more than an antibiotic.
    Hirsch R; Deng H; Laohachai MN
    J Periodontal Res; 2012 Apr; 47(2):137-48. PubMed ID: 22050485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The evaluation of the clinical efficacy and tolerance of azithromycin in odontostomatological infections].
    Varvara G; D'Arcangelo C
    Minerva Stomatol; 1998; 47(1-2):57-62. PubMed ID: 9578649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical response of azithromycin as an adjunct to non-surgical periodontal therapy in smokers.
    Mascarenhas P; Gapski R; Al-Shammari K; Hill R; Soehren S; Fenno JC; Giannobile WV; Wang HL
    J Periodontol; 2005 Mar; 76(3):426-36. PubMed ID: 15857078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin: a new concept in adjuvant treatment of periodontitis.
    Muniz FW; de Oliveira CC; de Sousa Carvalho R; Moreira MM; de Moraes ME; Martins RS
    Eur J Pharmacol; 2013 Apr; 705(1-3):135-9. PubMed ID: 23499686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of azithromycin in plasma, blood, polymorphonuclear neutrophils and sputum during long-term therapy in patients with cystic fibrosis.
    Wilms EB; Touw DJ; Heijerman HG
    Ther Drug Monit; 2006 Apr; 28(2):219-25. PubMed ID: 16628134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginine-nitric oxide-polyamine metabolism in periodontal disease.
    Ozer L; Elgun S; Ozdemir B; Pervane B; Ozmeric N
    J Periodontol; 2011 Feb; 82(2):320-8. PubMed ID: 20831369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of selective cyclooxygenase-2 inhibition on gingival tissue levels of prostaglandin E2 and prostaglandin F2alpha and clinical parameters of chronic periodontitis.
    Vardar S; Baylas H; Huseyinov A
    J Periodontol; 2003 Jan; 74(1):57-63. PubMed ID: 12593597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local concentration of systemic amoxicillin and metronidazole in healthy and inflamed gingiva: a comparative in vivo study.
    Amid R; Tabeie MB; Kadkhodazadeh M; Mehdizadeh AR; Youssefi N
    Drug Metabol Drug Interact; 2012 May; 27(2):113-8. PubMed ID: 22706234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azithromycin as an adjunctive treatment of aggressive periodontitis: 12-months randomized clinical trial.
    Haas AN; de Castro GD; Moreno T; Susin C; Albandar JM; Oppermann RV; Rösing CK
    J Clin Periodontol; 2008 Aug; 35(8):696-704. PubMed ID: 18631245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periodontal healing and bone regeneration in response to azithromycin.
    Hirsch R
    Aust Dent J; 2010 Jun; 55(2):193-9. PubMed ID: 20604763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Periodontal function and oral hygiene following an operation for apicoectomy].
    Iordanishvili AK
    Stomatologiia (Mosk); 1993; 72(1):77-9. PubMed ID: 8048112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of platelet-activating factor in gingival crevicular fluid and gingival tissue in specific periodontal diseases.
    Emingil G; Cinarcik S; Baylas H; Hüseyinov A
    J Periodontol; 2001 Aug; 72(8):1032-7. PubMed ID: 11525434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of leukotriene B4 in gingival crevicular fluid and gingival tissue in specific periodontal diseases.
    Emingil G; Cinarcik S; Baylas H; Coker I; Hüseyinov A
    J Periodontol; 2001 Aug; 72(8):1025-31. PubMed ID: 11525433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification and localization of platelet-derived growth factor in gingiva of periodontitis patients.
    Pinheiro ML; Feres-Filho EJ; Graves DT; Takiya CM; Elsas MI; Elsas PP; Luz RA
    J Periodontol; 2003 Mar; 74(3):323-8. PubMed ID: 12710751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.